Sheaff Brock Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $25.7M | Sell |
31,149
-1,091
| -3% | -$908K | 2.36% | 3 |
|
|
2024
Q4 | $24.9M | Buy |
32,240
+230
| +0.7% | +$190K | 2.16% | 4 |
|
|
2024
Q3 | $28.4M | Sell |
32,010
-2,447
| -7% | -$2.2M | 2.48% | 3 |
|
|
2024
Q2 | $31.2M | Sell |
34,457
-2,128
| -6% | -$1.7M | 2.89% | 3 |
|
|
2024
Q1 | $28.5M | Buy |
36,585
+163
| +0.4% | +$116K | 1.79% | 4 |
|
|
2023
Q4 | $21.2M | Sell |
36,422
-562
| -2% | -$328K | 1.64% | 5 |
|
|
2023
Q3 | $19.9M | Sell |
36,984
-4,977
| -12% | -$2.56M | 1.8% | 5 |
|
|
2023
Q2 | $19.7M | Sell |
41,961
-2,124
| -5% | -$891K | 1.66% | 5 |
|
|
2023
Q1 | $15.1M | Buy |
44,085
+333
| +0.8% | +$112K | 1.39% | 6 |
|
|
2022
Q4 | $16M | Sell |
43,752
-1,779
| -4% | -$631K | 1.58% | 6 |
|
|
2022
Q3 | $14.7M | Sell |
45,531
-3,721
| -8% | -$1.18M | 1.58% | 5 |
|
|
2022
Q2 | $16M | Sell |
49,252
-3,093
| -6% | -$928K | 1.33% | 5 |
|
|
2022
Q1 | $15M | Buy |
52,345
+571
| +1% | +$147K | 1.04% | 9 |
|
|
2021
Q4 | $14.3M | Buy |
51,774
+1,612
| +3% | +$409K | 0.96% | 9 |
|
|
2021
Q3 | $11.6M | Sell |
50,162
-4,665
| -9% | -$1.15M | 0.85% | 12 |
|
|
2021
Q2 | $12.6M | Buy |
54,827
+1,183
| +2% | +$238K | 0.91% | 10 |
|
|
2021
Q1 | $10M | Buy |
53,644
+554
| +1% | +$108K | 0.79% | 13 |
|
|
2020
Q4 | $8.96M | Sell |
53,090
-125
| -0.2% | -$18.7K | 0.75% | 16 |
|
|
2020
Q3 | $7.88M | Buy |
53,215
+28,248
| +113% | +$4.37M | 0.73% | 16 |
|
|
2020
Q2 | $4.1M | Sell |
24,967
-518
| -2% | -$79.5K | 0.41% | 49 |
|
|
2020
Q1 | $3.54M | Sell |
25,485
-1,245
| -5% | -$171K | 0.47% | 46 |
|
|
2019
Q4 | $3.51M | Buy |
26,730
+1,344
| +5% | +$156K | 0.34% | 59 |
|
|
2019
Q3 | $2.84M | Sell |
25,386
-1,263
| -5% | -$141K | 0.31% | 60 |
|
|
2019
Q2 | $2.95M | Sell |
26,649
-2,367
| -8% | -$279K | 0.32% | 61 |
|
|
2019
Q1 | $3.77M | Buy |
29,016
+513
| +2% | +$62.4K | 0.46% | 53 |
|
|
2018
Q4 | $3.3M | Buy |
28,503
+2,464
| +9% | +$275K | 0.52% | 54 |
|
|
2018
Q3 | $2.79M | Sell |
26,039
-14,518
| -36% | -$1.45M | 0.26% | 71 |
|
|
2018
Q2 | $3.46M | Sell |
40,557
-944
| -2% | -$77.5K | 0.34% | 59 |
|
|
2018
Q1 | $3.21M | Buy |
41,501
+9,299
| +29% | +$749K | 0.33% | 61 |
|
|
2017
Q4 | $2.72M | Sell |
32,202
-2,275
| -7% | -$194K | 0.35% | 64 |
|
|
2017
Q3 | $2.95M | Buy |
34,477
+1,527
| +5% | +$125K | 0.39% | 61 |
|
|
2017
Q2 | $2.71M | Sell |
32,950
-1,567
| -5% | -$128K | 0.36% | 61 |
|
|
2017
Q1 | $2.9M | Buy |
34,517
+623
| +2% | +$49.9K | 0.38% | 62 |
|
|
2016
Q4 | $2.49M | Buy |
33,894
+673
| +2% | +$50.1K | 0.32% | 72 |
|
|
2016
Q3 | $2.67M | Sell |
33,221
-2,381
| -7% | -$191K | 0.36% | 65 |
|
|
2016
Q2 | $2.8M | Buy |
35,602
+711
| +2% | +$53.5K | 0.36% | 64 |
|
|
2016
Q1 | $2.51M | Buy |
34,891
+763
| +2% | +$57.7K | 0.31% | 67 |
|
|
2015
Q4 | $2.88M | Buy |
+34,128
| New | +$2.83M | 0.33% | 66 |
|
Other funds holding LLY
Sheaff Brock Investment Advisors's LLY Position: Q1 2025 in Review
Sheaff Brock Investment Advisors reduced its Eli Lilly (LLY) stake by 3.4% in Q1 2025, selling an estimated $908K and leaving 31,149 shares worth $25.7M. The position accounts for 2.36% of the portfolio, ranked #3.
Sheaff Brock Investment Advisors first reported a position in LLY in Q4 2015 and has held it in 38 quarters since. The position peaked at $31.2M in Q2 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.
- Sheaff Brock Investment Advisors held 31,149 shares of Eli Lilly worth $25.7M as of Q1 2025.
- Sheaff Brock Investment Advisors sold 1,091 Eli Lilly shares in Q1 2025, an estimated $908K.
- Eli Lilly made up 2.36% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #3 holding.
- Sheaff Brock Investment Advisors first reported a position in Eli Lilly in Q4 2015 and has held it in 38 quarters since.
- Sheaff Brock Investment Advisors's Eli Lilly position peaked at $31.2M in Q2 2024.
- 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.
Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.